Dova Pharmaceuticals, Inc. (DOVA) Analysts See $-0.36 EPS; Pennantpark Investment (PNNT) Has 0.98 Sentiment

January 16, 2018 - By Winifred Garcia

PennantPark Investment Corporation specializes in direct and mezzanine investments in middle market companies. The company has market cap of $498.85 million. It invests in the form of mezzanine debt, senior secured loans, and equity investments. It has a 8.09 P/E ratio. The fund typically invests in building and real estate, hotels and gaming, electronics, healthcare, education and childcare, financial services, printing and publishing, consumer products, business services, energy and utilities, distribution, gas and oil, media, environmental services, aerospace and defense, manufacturing industries and retail.

Analysts expect Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) to report $-0.36 EPS on February, 8.After having $-0.38 EPS previously, Dova Pharmaceuticals, Inc.’s analysts see -5.26% EPS growth. The stock increased 0.68% or $0.2 during the last trading session, reaching $29.72. About 25,223 shares traded. Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) has 0.00% since January 16, 2017 and is . It has underperformed by 16.70% the S&P500.

Dova Pharmaceuticals, Inc., a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia diseases. The company has market cap of $762.39 million. The Company’s drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist that has completed Phase III clinical trials for the treatment of thrombocytopenia in patients with chronic liver diseases. It currently has negative earnings.

Ratings analysis reveals 75% of Pennant Investment’s analysts are positive. Out of 4 Wall Street analysts rating Pennant Investment, 3 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $8.0 while the high is $10.0. The stock’s average target of $8.67 is 23.50% above today’s ($7.02) share price. PNNT was included in 4 notes of analysts from August 6, 2015. The rating was upgraded by Ladenburg Thalmann to “Buy” on Tuesday, November 22. The stock has “Mkt Perform” rating by FBR Capital on Wednesday, November 23. DA Davidson initiated the shares of PNNT in report on Wednesday, September 30 with “Buy” rating. The firm earned “Buy” rating on Thursday, August 6 by MLV.

Greenwich Investment Management Inc. holds 5.13% of its portfolio in PennantPark Investment Corporation for 530,506 shares. Signia Capital Management Llc owns 438,549 shares or 3.38% of their US portfolio. Moreover, Muzinich & Co. Inc. has 1.7% invested in the company for 2.28 million shares. The Illinois-based West Family Investments Inc. has invested 0.78% in the stock. Sterneck Capital Management Llc, a Missouri-based fund reported 157,810 shares.

The stock increased 0.86% or $0.06 during the last trading session, reaching $7.02. About 360,880 shares traded. PennantPark Investment Corporation (PNNT) has risen 23.34% since January 16, 2017 and is uptrending. It has outperformed by 6.64% the S&P500.

Analysts await PennantPark Investment Corporation (NASDAQ:PNNT) to report earnings on February, 14. They expect $0.18 earnings per share, down 14.29% or $0.03 from last year’s $0.21 per share. PNNT’s profit will be $12.79M for 9.75 P/E if the $0.18 EPS becomes a reality. After $0.17 actual earnings per share reported by PennantPark Investment Corporation for the previous quarter, Wall Street now forecasts 5.88% EPS growth.